Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

Recruiting

• Conditions: Urinary Tract Infections

• Registration Number: NCT06910878
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-10-24
• Status Verified: 2025-03
• Study First Submitted: 2025-03-28
• Study First Submitted QC: 2025-03-28
• Last Update Submitted: 2025-03-28
• Study First Posted: 2025-04-04
• Last Update Posted: 2025-04-04
• Primary Completion: 2025-12-24
• Study Completion: 2025-12-24

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Adult (≥18 years old)
• Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
• Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
• The subject's primary care physician agreeing to participate in the study

Exclusion Criteria

• Subject and/or their primary care physician having expressed their opposition to participating in the study
• Subject under legal protection
• Subject under guardianship or curatorship

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs	Up to 1 year	Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs by general practitioners compared to current health authority recommendations

Trial Locations

Locations (1)

Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France